Status:
WITHDRAWN
The Relationships Between the Noradrenergic, Opioid and Pain System
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Experimental Pain Perception
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The role of alpha2 receptor agonist on pain perception and modulation will be examined. In addition whether this is mediated through the opioid system will be examined. Pain perception and modulation ...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Age 18-40
- No chronic disease
Exclusion
- Subjects who suffer from chronic pain / pain syndrome
- use of anti-depressant or anti-psychotic drugs
- suffering from cardiovascular disease
- breast feeding
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01851486
Start Date
January 1 2013
End Date
September 1 2016
Last Update
October 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel